Pharmacogenomics, Gene Therapy, Biosimilars, and Precision Medicine

Modern pharmaceutical sciences are increasingly focused on developing personalised and patient-specific approaches to disease prevention and treatment. Pharmacogenomics, gene therapy, biosimilars, and precision medicine are important areas that combine genetics, molecular biology, biotechnology, and pharmacology to improve therapeutic outcomes.

Pharmacogenomics is the study of how an individual’s genetic variations influence their response to medicines. Its general principle is that genetic differences can affect drug metabolism, efficacy, and adverse reactions. Pharmacogenomic information can therefore help in selecting the appropriate drug and dose for a particular patient. Its applications include cancer therapy, anticoagulant therapy, psychiatric medicines, and prediction of adverse drug reactions. It has considerable scope in developing safer and more effective personalised drug therapy.

Gene therapy involves introducing, modifying, replacing, or regulating genetic material to treat or prevent disease. It may use viral or non-viral vectors to deliver therapeutic genes to target cells. Gene therapy has applications in inherited genetic disorders, certain cancers, and other serious diseases. Its future scope includes development of more precise, safer, and long-lasting treatments.

Biosimilars are biological products that are highly similar to an already approved reference biologic and show no clinically meaningful differences in safety, purity, and efficacy. Their development can increase access to biological medicines and reduce treatment costs. Biosimilars have applications in diseases such as cancer, autoimmune disorders, and inflammatory conditions.

Precision medicine is an approach that considers individual differences in genes, environment, and lifestyle when selecting disease prevention and treatment strategies. It aims to provide the right treatment to the right patient at the right dose and at the right time. Together, these emerging fields have significant scope in improving therapeutic effectiveness, reducing adverse effects, accelerating drug development, and advancing the future of healthcare.

Click the link below to access detailed short notes and MCQs

https://drive.google.com/file/d/1cIMq0OLR6DrsF_cLSKHdiZ6fTpL1zOm0/view?usp=sharing

Dr Alok Singh